Imperial Capital analyst Michael Kim views positively Imperva's appointment of David Woodcock to SVP of Worldwide Sales. The hire "solidifies a key leadership post with a proven executive and largely completes the revamp of the management team," Kim tells investors in a research note. The analyst now sees lower risk of disruption for the global sales organization. He also thinks Europe's General Data Protection Regulation brings a potential growth inflection for Imperva from compliance. Kim views the stock's risk/reward as favorable and keeps an Outperform rating on the name with a $55 price target.